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113 30-day survivors of the Mustard repair undertaken between 1964 and
MLD(mm) Event Rate
Difference Treatment Control
Angiopeptin 0.01 22% 30% 003
CAVEAT I 0.11 28% 30% NS
BENESTENT 0.12 23% 33% <0.05
ACCORD 0.16 32% 32% NS
CAVEAT II 0.17 22% 33% 0.04
STRESS 0.20 20% 27% 008
The magnitude of the difference in MLD between the control and treat-
ment arms of each group is small in comparison with the difference in clin-
ical events detected, and there is no correlation between the magnitude of
MLD benefit and outcomes. Conclusion: While in some individual trials there
is concordance in angio-c1inical results, there is little evidence for this with
inter trial comparison. This suggests a treatment (medical or device) or trial
specific relationship rather than a direct linkage between MLD and clinical
outcomes.
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Long-term (28-Year) Follow-up of Mustard Repair for
Transposition of the Great Arteries with Intact




EEM area (mm2 ) 29.3 ± 118 204 ± 65 <0.0001
Lumen area (mm2 ) 8.5 ± 39 6.1 ± 2.4 <0.0001
Plaque area (mm 2) 20.9 ± 9.3 14.3 ± 5.7 <0.0001
Angiographic % diameter stenosis 9 ± 18 19± 14 0.0011
Follow-up
EEM area (mm2 ) 27.7 ± 9.5 187 ± 6.0 <0.0001
Lumen area (mm 2 1 6.5 ± 4.4 35 ± 3.0 <0.0001
Plaque area (mm 2) 22.0 ± 8.0 152 ± 5.5 <0.0001
Angiographic % diameter stenosis 36 ± 18 51 ± 26 0.005
Restenosis # (%) 8(23%) 77 (57%) 00017
Late lumen loss (mm2 ) 2.4 ± 2.6 2.6 ± 2.7 NS
Remodeling (mm2) 02 ± 13 1.7 ± 2.9 00061
Tissue growth (mm2) 2.2 ± 2.4 1.0 ± 2.3 0.0076
There is considerable controversy as to whether quantitative coronary angio-
plasty is a meaningful surrogate index for clinical outcomes after coronary
intervention. If a larger MLD reduces the incidence of restenosis, this in turn
should be associated with a decrease in the incidence of subsequent clinical
events. To study this phenomenon, we analyzed 6 major randomized trials
evaluating a variety of approaches to reduce restenosis following percuta-
neous revascularization. In 3 of the 6 trials compared to the control arm,
treatment was associated with significant decrease in the incidence of clin-
ical events secondary to restenosis Imyocardial infarction, death and need
for repeat revascularization) and an improvement in the MLD at the time of
follow-up catheterization. However, a similar or greater absolute MLD im-
provement did not yield clinical benefit in 2 trials, and 1 trial showed only
clinical benefit.
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Geometric remodeling is less (0.2 ± 1.3 vs 1.7 ± 2.9 mm2) and tissue
growth is greater (2.2 ± 2.4 vs 1.0 ± 2.3 mm2) in stented lesions than in
nonstented lesions. We Conclude: Stents reduce restenosis by achieving
a better primary (post-procedural) result and by eliminating geometric re-
modeling. The elimination of geometric remodeling offsets a stent-related
increase in plaque mass (tissue growth or neointimal hyperplasia) to prevent
restenosis.
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Dissociation Between Minimal Luminal Diameter and
Clinical Outcome at 6 Month Follow-up in Randomized
Trials of Percutaneous Revascularization
Robert L. Duerr. Eric J. Topol. Cleveland Clinic Foundation. Cleveland, OH
Factors Restenosis UN MR
No Yes
Lesions 256 64
Age 58 ± g 62 ± 9 0041 0.0001
Reference Vessel (mm) 3.35 ± 052 3.00 ± 0.52 0.0001 0.0001
Baseline MLD (mm) 0.97 ± 0.53 0.79 ± 044 0.019 ns
Final Stent MLD (mm) 3.46 ± 055 3.09 ± 0.52 0.0001 ns
Final % OS -8± 14 -5 ± 18 020 ns
Lesion Length (mml 8.8 ± 5.8 13 ± 7.8 00001 0.0001
Stent Number 1.4 ± 0.8 1.8 ± 13 00026 ns
Endovascular Stents Reduce Restenosis by
Eliminating Geometric Arterial Remodeling: A Serial
Intravascular Ultrasound Study
Gary S. Mintz, Augusto D. Pichard, Kenneth M. Kent, Lowell F. Satler, Jeffrey
J. Popma, S. Chiu Wong, Jack A. Painter, Debra DeForty, Martin B. Leon.
Washington Hospital Center. Washington, DC
MLD; Minimim lumen diameter, OS: Diameter stenosis
Conclusions. (1) In this cohort that had stent expansion optimized by IVUS
guidance, advanced age, small vessels and long lesion length were the
strongest independent predictors of restenosis. (2) These results confirm
previously reported analysis of angiographic data that small vessel diameter
is a strong predictor of restenosis. 13) Long lesion length rather than number
of stents is a stronger independent predictor of restenosis.
Intravascular ultrasound (IVUS) has been used to guide stent implantation
procedures and to optimize stent expansion. The long term effect that the im-
proved stent expansion achieved with IVUS guidance has on restenosis has
not been evaluated. Successful IVUS guided Palmaz Schatz coronary stent
implantation was performed in 429 consecutive lesions lies) in 359 patients
(pts).ln this cohort, based on IVUS evaluation, 70% of the stents required fur-
ther stent dilation despite an angiographic good result. Angiographic follow
up was obtained in 310 lesions (72%). Restenosis (by 50% diameter stenosis
criteria) occurred in 64 lesions (21 %). To determine the angiographic, clinical
and procedural factors associated with restenosis, univariate analysis (UN)
and stepwise logistical regression (MR) was performed on the 310 lesions
with angiographic follow up. The results between the restenosis (Yes) and
no restenosis (No) groups are summarized in the table below:
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Factors Associated with Late Angiographic Outcome
After Intravascular Ultrasound Guided Palmaz-Schatz
Coronary Stent Implantation: A Multivariate Analysis
Patrick Hall, Shigeru Nakamura, Luigi Maiello, Simonetta Blenglno,
Giovanni Martini, Leo Finci, Antonio Colombo. Columbus Hospital, Milan. Italy
11 :30
Previous studies have shown that (1) stents reduce restenosis, 12) stents
do not recoil, and (3) geometric remodeling may be an important contribut-
ing factor in restenosis. Therefore, to understand the mechanisms by which
stents reduce restenosis, we analyzed serial (post-intervention and follow-up
@ 5.0 ± 2.9 months) intravascular ultrasound and quantitative angiographic
studies in 33 stented lesions and compared the results to 135 nonstented le-
sions treated with various devices (30 PTCA, 57 directional and 26 rotational
atherectomy, and 22 excimer laser angioplasty). Post-intervention and follow-
up external elastic membrane (EEM), stent, and lumen areas were used to
calculate (1) plaque area, (2) late lumen loss (t. lumen area), (3) geometric
remodeling (I'. EEM area or I'. stent area in stented lesions and t.EEM area
in nonstented lesions), and (4) tissue growth t. (stent-lumen) area in stented
lesions and t. plaque area in nonstented lesions.
lesions that developed restenosis, versus 1.88 in the group that did not Ip
= 0.02). Similarly, diameter stenosis after BA was 43.4% versus 35.3%, re-
spectively (p < 0.0001), confirming previous studies.
As determined by 3 to 5 independent ICUS observers in each case, 86%
of lesions were ruptured (radial tear), with a restenosis rate of 32%, versus
18% in the non-ruptured lesions (p = 0.35). Dissection (circumferential tear)
was diagnosed in 64%, with a restenosis rate of 32%, versus 28% in the non-
dissected lesions (p = 0.65). Plaque type (soft 140%, restenosis 24%), hard
(10%, restenosis 27%) or calcific (50%, restenosis 33%), and eccentricity
(65%, restenosis 29%) did not predict the risk of restenosis. Two observers
independently measured lumen area, plaque area (media area minus lumen
area) and percent obstruction (plaque area/media area) on ICUS, and the two
values were averaged for analysis. There were no significant differences in
these parameters between groups with and without subsequent restenosis
Ip = 0.53, 0.44 and 0.16, respectively).
Conclusions: Qualitative and quantitative parameters on ICUS after suc-
cessful balloon angioplasty do not seem to predict the risk of angiographic
restenosis at 6 months.
